
- /
- Supported exchanges
- / F
- / EXK.F
Exact Sciences Corporation (EXK F) stock market data APIs
Exact Sciences Corporation Financial Data Overview
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Exact Sciences Corporation data using free add-ons & libraries
Get Exact Sciences Corporation Fundamental Data
Exact Sciences Corporation Fundamental data includes:
- Net Revenue: 2 692 M
- EBITDA: -11 337 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-07-28
- EPS/Forecast: -0.76
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Exact Sciences Corporation News

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the metr...


Trickle-down effect of NIH funding battle worries healthcare analysts and medical experts
Federal health research funding has faced a tumultuous four days after the Trump administration announced cuts Friday to a certain type of funding for the National Institutes of Health (NIH) — causi...

Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Wall Street expects a year-over-year decline in earnings on higher revenues when Exact Sciences (EXAS) reports results for the quarter ended December 2024. While this widely-known consensus outlook is...

When Can We Expect A Profit From Exact Sciences Corporation (NASDAQ:EXAS)?
With the business potentially at an important milestone, we thought we'd take a closer look at Exact Sciences Corporation's (NASDAQ:EXAS) future prospects. Exact Sciences Corporation provides cancer s...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.